Akoya Biosciences Files 2024 Annual Report Amendment
| Field | Detail |
|---|---|
| Company | Akoya Biosciences, Inc. |
| Form Type | 10-K/A |
| Filed Date | Apr 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, filing-update
TL;DR
Akoya Biosciences filed its 2024 10-K amendment on 4/28/25. Check for updates.
AI Summary
Akoya Biosciences, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, submitted on April 28, 2025, provides updated information regarding the company's operations and financial status. Akoya Biosciences, Inc. is headquartered in Marlborough, MA, and operates in the laboratory analytical instruments sector.
Why It Matters
This amendment to the annual report provides updated disclosures for investors and stakeholders regarding Akoya Biosciences' financial performance and operational status for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a 10-K/A filing, it indicates an amendment to a previously filed annual report, suggesting potential for revised financial data or disclosures that could impact investor understanding.
Key Numbers
- 2024 — Fiscal Year End (The annual report covers the fiscal year ending December 31, 2024.)
- April 28, 2025 — Filing Date (This amendment was filed on this date.)
Key Players & Entities
- Akoya Biosciences, Inc. (company) — Registrant
- December 31, 2024 (date) — Fiscal year end
- April 28, 2025 (date) — Filing date
- Marlborough, MA (location) — Company headquarters
- 001-40344 (other) — SEC file number
FAQ
What specific information was amended in the 10-K filing?
The filing is an amendment (10-K/A) to the annual report for the fiscal year ended December 31, 2024, indicating that specific sections or disclosures within the original 10-K have been revised or supplemented.
When was the original 10-K filed?
The filing date of the amendment is April 28, 2025, and it pertains to the fiscal year ended December 31, 2024. The original 10-K filing date is not explicitly stated in this header but would precede this amendment.
What is Akoya Biosciences, Inc.'s primary business sector?
Akoya Biosciences, Inc. is classified under the Standard Industrial Classification code 3826, which corresponds to Laboratory Analytical Instruments.
Where is Akoya Biosciences, Inc. located?
The company's business and mailing address is located at 100 Campus Drive, 6th Floor, Marlborough, MA 01762.
What is the SEC file number for Akoya Biosciences, Inc.?
The SEC file number for Akoya Biosciences, Inc. is 001-40344.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 28, 2025 regarding Akoya Biosciences, Inc..